A Study of Macitentan in Japanese Pediatric Participants With Pulmonary Arterial Hypertension
Clinical trial NCT05167825 · COMPLETED
Trial details
- NCT number
- NCT05167825
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-14
- Primary completion
- 2024-08-23
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.